Your browser does not support JavaScript! IMG (PHELLINUS LINTEUS MYCELIUM) TABLET [YEIN TRADING & GLOBAL CO., LTD]
DailyMed Logo Header image

Daily Med

Current Medication Information

Options

RxNorm Names

Out of scope

IMG (phellinus linteus mycelium) tablet
[Yein Trading & Global Co., Ltd]


Category DEA Schedule Marketing Status
HUMAN OTC DRUG LABEL unapproved drug other
NOTE:THIS DRUG HAS NOT BEEN FOUND BY FDA TO BE SAFE AND EFFECTIVE, AND THIS LABELING HAS NOT BEEN APPROVED BY FDA. For further information about unapproved drugs, click here.
Drug Label Sections

phellinus linteus mycelium

Zinc gluconate 3% (14.34% as Zinc), Vitamin C 10% (100% as vitamin C), Lactose 41%, Cordyceps militaris extract powder (mycelium culture) 6%, Chaga mushroom extract powder (mycelium culture) 6%, Ganoderma lucidum extract powder (mycelium culture) 6%, Trametes versicolor extract powder (mycelium culture) 6%, Grifola frondosa (mycelium culture) 6%, Hydroxypropylmethyl-cellulose 4%, Cultured Wild ginseng root powder 3%, Carboxymethylcellulose calcium 2%, Magnesium stearate 1%

antitumor effect
prophylactic effect
immunostimulating effect
synergistic effect

keep out of reach of the children

1. ulterine hemorrhage and hysterorrhea, dysmenorrhea, intestinal hemorrhage, activation of five organs and stomach function, detoxication
2. reinforcement of immune function by administration in parallel with any chemical therapy after any excising operation form the patient with cancer in digestive system or liver

- digestive system:  occasionally, vomiturition, vomiting, loss of appetite and diarrhea might occur, and infrequently malaise in stomach might take place
- the others:  dizziness (1 case), headache (1 case), constipation (3 cases) were reported in clinical test of this medicine

- uterine hemorrhage and hysterorrhea, dysmenorrhea, intestinal hemorrhage, activation of five organs and stomach function, detoxication : as a phellinus linteus mycelia extracts, administer 550~1100mg 2 times per a day before having a meal by mouth
- reinforcement of immune function by administration in parallel with any chemical therapy after any excising operation for the patient with cancer in digestive system or liver :  as a phellinus linteus mycelia extracts, administer 1100mg 3 times per a day after having a meal by mouth

package insert
IMG 
phellinus linteus mycelium tablet
Product Information
Product TypeHUMAN OTC DRUG LABELItem Code (Source)NDC:53144-3001
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PHELLINUS LINTEUS MYCELIUM (PHELLINUS LINTEUS MYCELIUM) PHELLINUS LINTEUS MYCELIUM0.022 
Inactive Ingredients
Ingredient NameStrength
ZINC GLUCONATE 
ASCORBIC ACID 
LACTOSE 
REISHI 
TRAMETES VERSICOLOR FRUITING BODY 
GRIFOLA FRONDOSA WHOLE 
HYPROMELLOSES 
CARBOXYMETHYLCELLULOSE CALCIUM 
MAGNESIUM STEARATE 
Product Characteristics
Colorbrown (light brown) Scoreno score
ShapeOVAL (pill) Size15mm
FlavorImprint Code 3;hp;x
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:53144-3001-160 in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other02/16/2013
Labeler - Yein Trading & Global Co., Ltd (557803795)
Registrant - Yein Trading & Global Co., Ltd (557803795)
Establishment
NameAddressID/FEIBusiness Operations
Han Kook Sin Yak Pharmaceutical Co., Ltd.689277536manufacture(53144-3001)

Revised: 2/2013
 
Yein Trading & Global Co., Ltd

Visit The National Library of Medicine Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services